Apo E4 Genotype as the Alzheimer Indictor in Korean Senior Subjects Aged 50 to 64 Years Old

남녀 노인층에서 Alzheimer위험 예측 인자로써의 Apo E4 Genotype에 관한 연구

  • Oh, Hyun-Hee (Department of Food & Nutrition, Family Health and Welfare Center (FHWC), Sungshin Women's University) ;
  • Shin, Eun-Jung (Department of Food & Nutrition, Family Health and Welfare Center (FHWC), Sungshin Women's University) ;
  • Kim, Hyun-Sook (Department of Food and Nutrition, Sookmyung Women's University) ;
  • Lim, Yun-Sook (Department of Food and Nutrition, Kyunghee University) ;
  • Park, Mi-Young (Department of Food and Nutrition, Sungshin Women's University) ;
  • Kim, Kkoch-Byul (Department of Food and Nutrition, Sungshin Women's University) ;
  • Kim, Eun-Mee (Department of Food and Nutrition, Sookmyung Women's University) ;
  • Lee, Myoung-Sook (Department of Food & Nutrition, Family Health and Welfare Center (FHWC), Sungshin Women's University)
  • 오현희 (성신여자대학교 가족건강복지센터 영양의학실) ;
  • 신은정 (성신여자대학교 가족건강복지센터 영양의학실) ;
  • 김현숙 (숙명여자대학교 식품영양학과) ;
  • 임윤숙 (경희대학교 생활과학대학 식품영양학과) ;
  • 박미영 (성신여자대학교 생활과학대학 식품영양학과) ;
  • 김꽃별 (성신여자대학교 생활과학대학 식품영양학과) ;
  • 김은미 (숙명여자대학교 식품영양학과) ;
  • 이명숙 (성신여자대학교 가족건강복지센터 영양의학실)
  • Published : 2007.10.30

Abstract

Recent studies described the ${\varepsilon}4$ allele of apoE confers a two-to fourfold increased risk for late-onset Alzheimer#s disease (LOAD), but LOAD pathology does not all fit neatly around apo E. Therefore, the goal of this study was to find the association between Alzheimer and apo E4 genotype in the 107 elderly between 50 to 64 years old who visited to FHWC of Sungshin Women#s University. We conducted the questionnaire survey (general & 24 hr dietary recall), anthropometerics (BP, waist & BMI) and blood biochemistry (FBS & lipid profiles). LDL-c and HOMA-IR were calculated by Friedwald#s and Matthew#s formulas. The apo E genotyping was performed by PCR-RFLP method and subjects were divided into three allele groups (${\varepsilon}3$; wild, ${\varepsilon}2$ & ${\varepsilon}4;$ mutants). The apo E allele frequencies were 7.0% for the ${\varepsilon}2$, 83.6% for the ${\varepsilon}3$ and 9.3% for the ${\varepsilon}4$. In comparison with biochemistry characteristics by apo E genotype, FBS was significantly higher in ${\varepsilon}4(129.2{\pm}6.8)$ than that in the others (${\varepsilon}2$: $117{\pm}7.4$, ${\varepsilon}3$: $107.3{\pm}2.2)$ (p<0.01). More than forty percents of ${\varepsilon}4$ group shown the dyslipidemia [high TG (>150mg/dl) & low HDL (<40 mg/dl:male or <50 mg/dl: female)]. The cytokines levels such as IL-1 ${\beta}$, IL-6 and $TNF-{\alpha}$ were not different among three apoE alleles. After the adjusting sex, age & dietary fiber, LDL-c level was siginificantly higher in ${\varepsilon}4$ ($108.3{\pm}7.7$) than that in ${\varepsilon}2$ ($100.4{\pm}8.4$) (p<0.05). According to food intake and the recipe on the basis of 24 hr dietary recall, the elder]y with ${\varepsilon}4$ allele took higher intake frequency of the light -colored vegetable (radish, onion & cabbage) and pan-fried foods (sauteed beef and vegetables, stir-fried vienna with vegetables) than the others. We knew that the elderly with ${\varepsilon}4$ allele had been restricted the calories intakes with high dietary fiber (33.6+2.5 g/d) to maintain the normal level of FBS and LDL-c. On next study, the prevalence of Alzheimer#s disease in this population who has ${\varepsilon}4$ allele on the condition of calories restriction will be continually follow-up.

Keywords

References

  1. Nam KK, Lee HS, Yoo KJ. Diagnosis and Treatment of Dementia. Korea J Gerontological Society 1993; 13 (2): 168-177
  2. Azad NA, Al Buqami M. Gender differences in dementia risk factors, Gend Med 2007; 4 (2): 120-129 https://doi.org/10.1016/S1550-8579(07)80026-X
  3. Kim SY. Factors affecting on the QOL of the demented elderly caregivers, Social Welfare Policy 2003; 17: 77-105
  4. Lee EH. Impact of family function in the burden of caregiving elderly dementia patients, Journal of Welfarefor the Aged 2003; 19; 173-197
  5. Huang Y. Apolipoprotein E and Alzheimer disease, Neurology 2006; 66: 79-85 https://doi.org/10.1212/01.wnl.0000192102.41141.9e
  6. Hu CJ, Sung SM, Liu HC, Hsu WC, Lee LS, Lee CC, Tsai CH, Chang JO, Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan, Journal ofthe Neurological Sciences 2000; 181: 127-131 https://doi.org/10.1016/S0022-510X(00)00443-3
  7. Cedazo-Minquez A, Popescu BO, Blanco-Millan JM, Akterin S, Pei JJ, Winblad B, Cowburn RF. Apolipoprotein E and beta-amyloid regulation of glycogen synthase kinase-3beta. J Neurochem 2003; 87(5): 1152-1164 https://doi.org/10.1046/j.1471-4159.2003.02088.x
  8. Prince JA, Zetterberq H, Andreasen N, Marcusson J, Blennow K. ApoE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42. Neurology 2004; 62 (11): 2116-2118 https://doi.org/10.1212/01.WNL.0000128088.08695.05
  9. Paula G. LRP in Alzheimer's disease: friend or foe? J Clin Invest 2000; 106 (9): 1077-1079 https://doi.org/10.1172/JCI11455
  10. Changen YU, Howard Seltman, Elaine R Peskind, Nichole Galloway, et al. Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: Patterns of linkage disequilibrium and disease/marker association. J Genomics 2007; 89: 655-665 https://doi.org/10.1016/j.ygeno.2007.02.002
  11. Yiqing Song, JoAnn EM, Lesley Tinker, Barbara VH, Lewis HK, Lauren Nathan, Nader Rifai, Simin Liu. Inulin sensitivity and insulin secretion determined by homeostasis model assessment (HOMA) and risk of diabetes in a Multiethnic cohort of women: the women's health initiative observational study. Diabetes Care 2007; 30(7): 1747-1752 https://doi.org/10.2337/dc07-0358
  12. Kang SM, Woo JT, Kim SW, Yang IM, Kim JW, Kim YS, Kim KW, Choi YK, Paeng JY. Apolipoprotein E genotypes in patients with diabetes, cerebrovascular accident, and acute myocardial infarction. Korean J Endocrine Society 1992; 7 (3); 273-279
  13. Kim IJ, Hong BK, Lee BW, Kwon HM, Kim DS, Choi ET, Byun KH, Kim JR, Song KS, Kim HS. Apolipoprotein E polymorphism in Non-diabetic pations with acute coronary syndrome. J Yonsei Medical 1999; 40 (4): 377-382 https://doi.org/10.3349/ymj.1999.40.4.377
  14. Gamboa R, Hernandez-Pacheco G, Hesiquio R, Zuniqa J, Masso F, Montano LF, Ramos-Kuri M, Estrada J, Granados J, VarqasAlarcon G. Apolipoprotein E polymorphism in the Indian and Mestizo populations of Mexico. Hum Biol 2000; 72: 975-981
  15. Mendes-Lana A, Pena GG, Freitas SN, Lima AA, Nicolato RLC, Nascimento-Neto RM, Machado-Coelho GLL, Freitas RN. Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto study. Brazilian Journal of Medical and Biological Research 2007; 40: 49-56 https://doi.org/10.1590/S0100-879X2007000100007
  16. Lee DM, Lee SO, Mun BS, Ahn HS, Park HY, Lee HS, Kim DG. Relation of apolipoprotein E polymorphism to clinically diagnosed fatty liver disease. Korean J Associationfor the Study of the Liver 200; 8 (4) ; 355-362
  17. Balakrishnan K, Verdile G, Mehta PD, Beilby J, Nolan D, Ga1vao DA, Newton R, Gandy SE, Martins RN. Plasma Abeta42 correlates positively with increased body fat in healthy individuals. J Alzheimers Dis 2005; 8 (3); 269-282 https://doi.org/10.3233/JAD-2005-8305
  18. van den Berq E, Kessels RP, Kappelle LJ, de Haan EH, Biessels GJ. Type 2 diabetes, cognitive function and dementia: Vascular and metabolic determinants. Drugs Today (Bare) 2006; 42 (11) : 741-754 https://doi.org/10.1358/dot.2006.42.11.1003542
  19. Laederach-Hofrnann K, Kupferschmid S, Mussgay L. Links between body mass index, total body fat, cholesterol, high-density lipoprotein, and insulin sensitivity in patients with obesity related to depression, anger and anxiety. Int J Eat Disord 2002; 32 (1) : 58-71 https://doi.org/10.1002/eat.10063
  20. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, Apo E gene and the risk for dementia and related pathologies: The HonoluluAsia Aging Study. Diabetes 2002; 51 (4): 1256-1262
  21. Ali K, Middleton M, Pure E, Rader DJ. Apolipoprotein E suppresses the type I inflammatory response in vivo. Circ Res 2005; 97 (9) : 922-927 https://doi.org/10.1161/01.RES.0000187467.67684.43
  22. Sciacca FL, Ferri C, Licastro F, Veglia F, Biunno I, Gavazzi A, Calabrese E, Martinelli Boneschi F, Sorbi S, Mariani C, Franceschi M, Grimaldi LME. Interleukin-I b polymorphism is associated with age at onset of Alzheimer's disease. Neurobiology of Aging 2003; 24: 927-931 https://doi.org/10.1016/S0197-4580(03)00011-3
  23. Erin M Ramos, Ming-Tesh Lin, Eric B Larson, Izumi Maezawa, Li-Hui Tseng, Karen L Edwards, Gerard D Schellenberg, John A Hansen, Walter A Kukull, Lee-Way Jin. Tumor necrosis factor ${\alpha}$ and interleukin 10 promoter region polymorphisms and risk of late-onset alzheimer disease. Arch Neurol 2006; 63: 1165-1169 https://doi.org/10.1001/archneur.63.8.1165
  24. Park MY, Kim GR, Lee DJ, Kim JM, Park PS. A survey offood and nutrient intakes of the eged people in rural area, Gyeongbuk Yecheon. Korea J Nutrition Society 2006; 39 (1); 58-73
  25. Uh SB, Kim HS, Back K, Kang KW, Yuk JY, Kim BS. A study on risk factors of nutrition in a fural aged people. Korea Sport Research 2005; 16 (6): 237-250
  26. Morris MC, Evans DA, Baienias JL, Tanqney CC, Bennett DA, Wilson RS, Aqqurwal N, Schneider J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60 (7): 923-924 https://doi.org/10.1001/archneur.60.7.923
  27. Syrah Khan, Anne-marie Minihane, Philippa J Talmud, John W Wright, Margaret C Murphy, Christine M Williams, Bruce A Griffin. Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype. J Lipid Res 2002; 43: 979-985
  28. Lee MS, Kim JQ, Kim Jw. Studies on the distribution of plasma lipid profiles in Korean hyperlipidemia according to hyperlipoproteinemia (HLP) and apo E polymorphism. Korea J Nutr Society 2000; 33 (6) : 639-646